2025-07-14 - Analysis Report
Okay, here's an analysis of Colgate-Palmolive (CL) based on the provided data.

**Report on Colgate-Palmolive Co (CL)**

**0. Summary of Key Numbers**

*   **Cumulative Return (CL):** 17.07%
*   **Cumulative Return (S&P 500/VOO):** 95.46%
*   **Return Disparity (vs. VOO):** -78.4% (Relative Disparity: 0.0%)
*   **Last Price:** $89.58
*   **5-Day Moving Average:** $91.45
*   **20-Day Moving Average:** $90.23
*   **60-Day Moving Average:** $91.18
*   **Market Risk Indicator (MRI):** 0.3294
*   **RSI:** 58.11
*   **PPO:** 0.1056
*   **Expected Return (vs. S&P 500):** -3595.6%

**1. Return Analysis vs. S&P 500 (VOO)**

*   **Ticker:** CL
*   **Company:** Colgate-Palmolive Co
*   **Description:** Colgate-Palmolive is a global consumer products company specializing in the production, distribution, and provision of household, health care, personal care, and veterinary products.
*   **Cumulative Return (CL):** 17.07%
*   **Cumulative Return (VOO):** 95.46%
*   **Return Disparity:** -78.4% (Relative Disparity: 0.0%)

The provided data indicates a significant underperformance of Colgate-Palmolive (CL) compared to the S&P 500 (VOO) over the specified period. The cumulative return of CL is 17.07%, while VOO shows a return of 95.46%, resulting in a disparity of -78.4%. A relative disparity of 0.0% suggests that the current return difference is at the lower end of its historical range.

**Alpha and Beta Analysis:**

| Year       | CAGR     | MDD      | Alpha   | Beta   | Cap(B) |
| :----------- | :------- | :------- | :------ | :----- | :----- |
| 2015-2017  | 13.0%    | 4.5%     | -16.0%  | 0.0    | 60.4   |
| 2016-2018  | -11.0%   | 65.2%    | -29.0%  | 0.1    | 47.7   |
| 2017-2019  | 7.0%     | 65.2%    | -22.0%  | 0.1    | 55.1   |
| 2018-2020  | 18.0%    | 65.2%    | -2.0%   | 0.6    | 68.5   |
| 2019-2021  | 30.0%    | 58.6%    | -19.0%  | 0.7    | 68.4   |
| 2020-2022  | 7.0%     | 69.0%    | 5.0%    | 0.7    | 63.1   |
| 2021-2023  | 6.0%     | 69.0%    | -12.0%  | 0.8    | 63.9   |
| 2022-2024  | 13.0%    | 69.0%    | -12.0%  | 0.8    | 72.8   |
| 2023-2025  | 4.0%     | 70.6%    | -43.0%  | 0.3    | 71.8   |

*   **CAGR:** The Compound Annual Growth Rate varies, with some periods showing positive growth and others negative.
*   **MDD:** The Maximum Drawdown is consistently high across the periods, indicating significant potential losses during downturns.
*   **Alpha:** The Alpha values are mostly negative, suggesting that CL has generally underperformed its benchmark on a risk-adjusted basis, except for the 2020-2022 period.
*   **Beta:** The Beta values are low, indicating that CL is less sensitive to market movements.
*   **Cap(B):** The market capitalization is generally stable, indicating a relatively consistent size of the company over the analyzed periods.

**2. Recent Stock Price Movements**

*   **Current Price:** $89.58
*   **Last Market Price:** $88.55 (Change: -1.15)
*   **5-Day Moving Average:** $91.45
*   **20-Day Moving Average:** $90.23
*   **60-Day Moving Average:** $91.18

The current price of $89.58, with the last market price at $88.55 (down 1.15), suggests a recent downward price movement. The 5-day moving average is higher than the 20-day and 60-day moving averages, indicating a potential short-term upward trend that might be reversing given the recent price drop.

**3. Technical Indicators and Expected Return**

*   **Market Risk Indicator (MRI):** 0.3294 (Low Risk)
*   **RSI:** 58.11
*   **PPO:** 0.1056
*   **Hybrid Signal:** cash_0%_Buy 80% of cash (2 shares - Caution - MRI:0.34)
*   **Delta_Previous_Relative_Divergence:** 0.0 (Negative - Short-term Decline)
*   **Expected Return (vs. S&P 500):** -3595.6%

The Market Risk Indicator (MRI) suggests a low-risk environment for the stock. The RSI of 58.11 indicates that the stock is neither overbought nor oversold. The Hybrid Signal recommends buying a portion of cash with caution due to the MRI, suggesting a balanced approach. The negative change in relative divergence indicates a short-term downward trend. The significantly negative expected return compared to the S&P 500 suggests that the stock is not expected to outperform the market in the long term. The significant price change from the previous close ($1.15) does represent a noteworthy short term event.

**4. Recent News & Significant Events**

*   **[2025-07-14]:** Colgate-Palmolive Co (CL) has recently made headlines due to major business developments, regulatory changes, or market events.
*   **[2025-07-10]:** Analysts are discussing Colgate-Palmolive Co's (CL) recent performance and its outlook in the context of industry trends and global economic factors.
*   **[2025-07-12]:** Colgate-Palmolive Co (CL)'s stock has shown notable volatility, influenced by recent news, earnings reports, or executive actions.
*   **[2025-07-13]:** Market experts highlight both risks and opportunities for Colgate-Palmolive Co (CL), advising investors to monitor recent news and company announcements.

Recent news indicates that Colgate-Palmolive is experiencing volatility and is subject to discussions regarding its performance and outlook. These events could be influencing the stock's price movements and investor sentiment.

**5. Recent Earnings Analysis**

| 날짜         | EPS  | 매출     |
| :----------- | :--- | :------- |
| 2025-04-25   | 0.85 | 4.91 B$  |
| 2024-10-25   | 0.9  | 5.03 B$  |
| 2024-07-26   | 0.89 | 5.06 B$  |
| 2024-04-26   | 0.83 | 5.07 B$  |
| 2025-04-25   | 0.83 | 5.07 B$  |

The EPS and revenue figures show some fluctuation over the recent quarters. While revenue has generally been around $5 billion, the EPS has varied from $0.83 to $0.9. The slight decrease in revenue and EPS in the most recent quarter could be a concern.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter    | Revenue   | Profit Margin |
| :--------- | :-------- | :------------ |
| 2025-03-31 | $4.91B   | 60.82%        |
| 2024-12-31 | $4.95B   | 60.30%        |
| 2024-09-30 | $5.03B   | 61.08%        |
| 2024-06-30 | $5.06B   | 60.62%        |
| 2024-03-31 | $5.07B   | 60.00%        |

**Capital and Profitability:**

| Quarter    | Equity   | ROE       |
| :--------- | :------- | :-------- |
| 2025-03-31 | $0.36B   | 190.08%   |
| 2024-12-31 | $0.21B   | 348.58%   |
| 2024-09-30 | $0.43B   | 169.43%   |
| 2024-06-30 | $0.12B   | 594.31%   |
| 2024-03-31 | $0.23B   | 296.96%   |

The revenue has been relatively stable around $5 billion, with a slight decrease in the most recent quarter. The profit margin has remained consistently high, around 60%. The Equity has fluctuated, but the ROE has remained exceptionally high, indicating efficient use of equity.

**7. Comprehensive Analysis**

Based on the provided data, Colgate-Palmolive (CL) presents a mixed picture:

*   **Underperformance:** CL has significantly underperformed the S&P 500 (VOO) over the analyzed period.
*   **Low Market Sensitivity:** The low Beta values suggest that CL is less sensitive to market movements, which can be both a pro and a con depending on market conditions.
*   **Recent Price Decline:** Recent price movements indicate a short-term downward trend.
*   **Low Risk:** The Market Risk Indicator (MRI) suggests a low-risk environment, but the Hybrid Signal still advises caution.
*   **Inconsistent Earnings:** The EPS and revenue figures show some fluctuation, with a slight decrease in the most recent quarter.
*   **High Profitability and ROE:** The company has maintained high profit margins and ROE, indicating efficient operations.
*   **Negative Expected Return:** The significantly negative expected return compared to the S&P 500 suggests that the stock is not expected to outperform the market in the long term.

**Overall Recommendation:**

Given the underperformance, recent price decline, inconsistent earnings, and negative expected return, caution is advised. Investors should closely monitor the stock's performance and consider the potential risks before making any investment decisions. The recent news and volatility further warrant careful consideration. While the high profitability and ROE are positive indicators, they do not outweigh the other concerning factors.
